IRIS Accounts Production v26.1.10.60 SC440948 Board of Directors 1.4.25 31.3.26 31.3.26 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC4409482025-03-31SC4409482026-03-31SC4409482025-04-012026-03-31SC4409482024-03-31SC4409482024-04-012025-03-31SC4409482025-03-31SC440948ns15:Scotland2025-04-012026-03-31SC440948ns14:PoundSterling2025-04-012026-03-31SC440948ns10:Director12025-04-012026-03-31SC440948ns10:PrivateLimitedCompanyLtd2025-04-012026-03-31SC440948ns10:SmallEntities2025-04-012026-03-31SC440948ns10:AuditExempt-NoAccountantsReport2025-04-012026-03-31SC440948ns10:SmallCompaniesRegimeForDirectorsReport2025-04-012026-03-31SC440948ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-31SC440948ns10:FullAccounts2025-04-012026-03-31SC440948ns10:OrdinaryShareClass12025-04-012026-03-31SC440948ns10:Director22025-04-012026-03-31SC440948ns10:Director32025-04-012026-03-31SC440948ns10:Director42025-04-012026-03-31SC440948ns10:RegisteredOffice2025-04-012026-03-31SC440948ns5:CurrentFinancialInstruments2026-03-31SC440948ns5:CurrentFinancialInstruments2025-03-31SC440948ns5:ShareCapital2026-03-31SC440948ns5:ShareCapital2025-03-31SC440948ns5:RetainedEarningsAccumulatedLosses2026-03-31SC440948ns5:RetainedEarningsAccumulatedLosses2025-03-31SC440948ns5:FurnitureFittings2025-04-012026-03-31SC440948ns5:ComputerEquipment2025-04-012026-03-31SC440948ns5:FurnitureFittings2025-03-31SC440948ns5:MotorVehicles2025-03-31SC440948ns5:ComputerEquipment2025-03-31SC440948ns5:MotorVehicles2025-04-012026-03-31SC440948ns5:FurnitureFittings2026-03-31SC440948ns5:MotorVehicles2026-03-31SC440948ns5:ComputerEquipment2026-03-31SC440948ns5:FurnitureFittings2025-03-31SC440948ns5:MotorVehicles2025-03-31SC440948ns5:ComputerEquipment2025-03-31SC440948ns5:WithinOneYearns5:CurrentFinancialInstruments2026-03-31SC440948ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-31SC440948ns5:DeferredTaxation2025-03-31SC440948ns5:DeferredTaxation2025-04-012026-03-31SC440948ns5:DeferredTaxation2026-03-31SC440948ns10:OrdinaryShareClass12026-03-31
REGISTERED NUMBER: SC440948 (Scotland)















Unaudited Financial Statements for the Year Ended 31 March 2026

for

Glasgow Colorectal Ltd

Glasgow Colorectal Ltd (Registered number: SC440948)






Contents of the Financial Statements
for the Year Ended 31 March 2026




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Glasgow Colorectal Ltd

Company Information
for the Year Ended 31 March 2026







DIRECTORS: Dr Andrew Renwick
Mrs Jill Renwick
Robbie Renwick
Miss Grace Renwick





REGISTERED OFFICE: 111 Balshagray Avenue
Glasgow
G11 7EG





REGISTERED NUMBER: SC440948 (Scotland)





ACCOUNTANTS: Stevenson & Kyles
Chartered Accountants
25 Sandyford Place
Glasgow
G3 7NG

Glasgow Colorectal Ltd (Registered number: SC440948)

Balance Sheet
31 March 2026

2026 2025
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 82,314 24,798

CURRENT ASSETS
Debtors 5 5,138 9,814
Cash at bank 99,302 142,090
104,440 151,904
CREDITORS
Amounts falling due within one year 6 76,953 110,197
NET CURRENT ASSETS 27,487 41,707
TOTAL ASSETS LESS CURRENT
LIABILITIES

109,801

66,505

PROVISIONS FOR LIABILITIES 7 18,109 5,455
NET ASSETS 91,692 61,050

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 91,592 60,950
SHAREHOLDERS' FUNDS 91,692 61,050

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Glasgow Colorectal Ltd (Registered number: SC440948)

Balance Sheet - continued
31 March 2026


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 5 June 2026 and were signed on its behalf by:





Mrs Jill Renwick - Director


Glasgow Colorectal Ltd (Registered number: SC440948)

Notes to the Financial Statements
for the Year Ended 31 March 2026

1. STATUTORY INFORMATION

Glasgow Colorectal Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fittings and equipment - 15% on reducing balance
Computer equipment - 33.33% on cost

Financial instruments
Basic financial instruments, including debtors and creditors with no stated interest rate and receivable or payable within one year, are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in administrative expenses.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Glasgow Colorectal Ltd (Registered number: SC440948)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2025 - 4 ) .

4. TANGIBLE FIXED ASSETS
Fittings
and Motor Computer
equipment vehicles equipment Totals
£    £    £    £   
COST
At 1 April 2025 4,582 52,675 9,931 67,188
Additions - 99,718 - 99,718
Disposals - (52,675 ) - (52,675 )
At 31 March 2026 4,582 99,718 9,931 114,231
DEPRECIATION
At 1 April 2025 2,650 31,605 8,135 42,390
Charge for year 290 19,944 898 21,132
Eliminated on disposal - (31,605 ) - (31,605 )
At 31 March 2026 2,940 19,944 9,033 31,917
NET BOOK VALUE
At 31 March 2026 1,642 79,774 898 82,314
At 31 March 2025 1,932 21,070 1,796 24,798

Glasgow Colorectal Ltd (Registered number: SC440948)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade debtors 4,436 1,829
Other debtors 702 7,985
5,138 9,814

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Taxation and social security 17,793 18,471
Other creditors 59,160 91,726
76,953 110,197

7. PROVISIONS FOR LIABILITIES
2026 2025
£    £   
Deferred tax 18,109 5,455

Deferred
tax
£   
Balance at 1 April 2025 5,455
Provided during year 12,654
Balance at 31 March 2026 18,109

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2026 2025
value: £    £   
100 Ordinary £1 100 100

9. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Mrs Jill Renwick.